Share of Jubilant Pharmova Ltd is currently trading at around Rs.1026/-Investors are asking for the Jubilant Pharmova Share Price Target for 2025, 2030, 2035 and 2040. In this article, we will discuss about the business prospects and financial performance of the Company and based on our discussion and analysis will tell you the Jubilant Pharmova Share Price Target for 2025, 2030, 2035 and 2040.
Discussion & Analysis of Business & Financial performance with future business prospects of Jubilant Pharmova Ltd:
Jubilant Pharmova Ltd stands as a prominent player in the global pharmaceutical and life sciences sector, with a diversified portfolio spanning radiopharma, contract development and manufacturing (CDMO), generics, and proprietary novel drugs. Headquartered in India, the company has built a robust international presence, serving regulated markets across North America, Europe, and Asia.
🏢 Current Business Position
As of FY 2024–25, Jubilant Pharmova has demonstrated strong financial resilience and strategic clarity. The company reported record profits and announced a 500% dividend payout, signaling robust cash flows and shareholder confidence. Its business segments are well-integrated, with radiopharmaceuticals and sterile injectables contributing significantly to revenue. The CDMO division, which includes drug discovery services and active pharmaceutical ingredients (APIs), continues to attract global clients due to its quality standards and regulatory compliance
The company’s shareholding pattern reflects a healthy mix of promoters (47.68%), retail investors (25.39%), and institutional stakeholders including foreign institutions and mutual funds. This balanced structure underscores investor trust and long-term stability.
Operationally, Jubilant Pharmova maintains a relatively low beta (0.84), indicating less volatility compared to broader market indices. Its book value per share stands at ₹372.96, with a market capitalization of ₹17,106 crore as of August 2025. These metrics point to a stable and mature business model with consistent earnings and moderate risk.
🚀 Future Business Prospects
Looking ahead, Jubilant Pharmova is poised for sustained growth driven by several strategic levers:
· Innovation & R&D: The company’s focus on precision oral medicines and novel drug development positions it well for breakthroughs in therapeutic areas with unmet needs.
· Global Expansion: With increasing demand for CDMO services and APIs, Jubilant is expected to deepen its footprint in regulated markets, especially North America and Europe.
· Digital Transformation: Investments in automation, data analytics, and AI-driven drug discovery are likely to enhance operational efficiency and reduce time-to-market.
· Sustainability & CSR: Jubilant’s commitment to sustainable development and corporate social responsibility adds long-term brand value and aligns with global ESG trends
From an investment perspective, analysts project a steady upward trajectory in share price targets—from ₹1,100–₹1,180 in 2025 to ₹1,900–₹2,200 by 2030. This growth is expected to be fueled by stable global pharma demand, improved margins, and strategic partnerships.
📊 Strategic Outlook
Jubilant Pharmova’s ability to balance innovation with operational excellence makes it a compelling case for long-term investors and industry watchers. Its diversified revenue streams, strong promoter backing, and global reach provide a cushion against sectoral volatility. As the pharmaceutical landscape evolves, Jubilant’s agility and commitment to quality will likely keep it at the forefront of industry transformation.
Share Price Targets:
Jubilant Pharmova Share Price Target 2025
Based on the above discussion and analysis, the share price of Jubilant Pharmova Ltd may touch the level of around Rs.1125-1150 in 2025
Jubilant Pharmova Share Price Target 2030
Based on the above discussion and analysis, the share price of Jubilant Pharmova Ltd may touch the level of around Rs.2300-2500 in 2030
Jubilant Pharmova Share Price Target 2035
Based on the above discussion and analysis, the share price of Jubilant Pharmova Ltd may touch the level of around Rs.5000-5500 in 2035
Jubilant Pharmova Share Price Target 2040
Based on the above discussion and analysis, the share price of Jubilant Pharmova Ltd may touch the level of around Rs.11000-12000 in 2040
Disclaimer:Investment in Capital Market/Share Prices are subject to market fluctuations and are dependent on several factors. These predictions are based on the current market conditions and the future market expectations. Investors are advised to take into consideration all these factors before making any investment in Capital Market. This article should not be treated as Investment advisory and is for general Guidance & Educational purpose only. We keep revising our share price targets based on the latest information available with us. Please keep visiting our website regularly to keep yourself updated. MoneyInsight does not offer investment advice and does not encourage any action based on its content.
Read Also:
How to make maximum profit with minimum investment from the Stock Market ? – MoneyInsight
Also Read :
How to make money from share market? (indiatimes.com)
Visit our another Group Website regularly for more such Educational Research Articles:
News4You – News & Views On Personal Finance & Share Market
Visit our Website regularly for more such Educational Research Articles:
MoneyInsight – We Provide Insight to Your Money
